FPW
AGIO icon

Flagship Private Wealth’s Agios Pharmaceuticals AGIO Stock Holding History

Flagship Private Wealth’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-50
Closed -$2.84K – 80
2021
Q2 		$2.84K Hold
50
– – ﹤0.01% 303
2021
Q1 		$2.74K Hold
50
– – ﹤0.01% 272
2020
Q4 		$2.29K Buy
+50
New +$1.98K ﹤0.01% 296

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Flagship Private Wealth's AGIO Position: Q3 2021 in Review

Flagship Private Wealth sold out of Agios Pharmaceuticals (AGIO) in Q3 2021, closing a stake of 50 shares — an estimated $2.84K sold.

Flagship Private Wealth first reported a position in AGIO in Q4 2020 and held it in 3 quarters. The position peaked at $2.84K in Q2 2021. 164 funds tracked by Wall St. Rank hold AGIO as of Q3 2021.

  • Flagship Private Wealth reported no remaining Agios Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Flagship Private Wealth sold 50 Agios Pharmaceuticals shares in Q3 2021, an estimated $2.84K.
  • Flagship Private Wealth first reported a position in Agios Pharmaceuticals in Q4 2020 and held it in 3 quarters.
  • Flagship Private Wealth's Agios Pharmaceuticals position peaked at $2.84K in Q2 2021.
  • 164 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2021.

Based on Flagship Private Wealth's 13F filing for Q3 2021, filed 20 Oct 2021.